Comprehensive Analysis of Allulose Production: Review and Update

The production process matters

If you buy D-allulose, production technology should be part of your supplier conversation. A new review in Foods (DOI 10.3390/foods13162572) updates the field. The changes are practical. The authors focus on enzymatic conversion, from immobilization to directed evolution to metabolic pathway engineering. Here’s what matters for people who actually make products.

Why regulators changed the game

Regulation helped push allulose into the mainstream. In 2019, the FDA recognized allulose as GRAS. China’s NHC also approved it as a new food ingredient. That gave formulators a sweetener with the bulk and mouthfeel of sugar, plus regulatory cover to use it in more products. But approvals only help if production can keep pace. The review explains how much progress has been made on that front.

What the review covers

The authors did not stop at one enzyme. They scanned the whole production landscape. The review covers immobilized enzymes, which let manufacturers reuse biocatalysts. It also covers new enzyme discovery, directed evolution, and metabolic pathway modification. That last one matters because it moves allulose production beyond simple enzymatic steps toward whole-cell biosynthesis.

What the evidence shows

The core chemistry remains D-fructose to D-allulose. The most striking evidence in the review is a multi-enzyme cascade used for juice biotransformation. In that system, D-fructose reached a 75% conversion rate. Total yield hit 60%. Those numbers tell a formulator a lot. They show the reaction works in a complex food matrix, not just a clean buffer solution.

Approach	Reported outcome	Formulator relevance
Immobilized enzymes	Reusable biocatalysts support repeated conversion	Lower enzyme cost per production batch
Novel enzyme discovery	New biocatalysts expand process flexibility	More options for pH, temperature, and substrate tolerance
Directed evolution	Enzymes tailored for better performance	Higher selectivity under food-grade conditions
Metabolic pathway engineering	Biosynthetic routes beyond single-step conversion	Potential for fermentation-based production at scale
Multi-enzyme cascade in juice	75% conversion; 60% total yield	Direct biotransformation of fruit juice with less downstream refining

What it means for your formulations

For buyers, this review is a reminder that enzyme technology is a competitive variable. Immobilized enzymes reduce the enzyme cost per kilo. Directed evolution and new enzyme discovery give suppliers tools to design enzymes for specific processing conditions. Metabolic pathway engineering opens the door to fermentation, and that could change the scale and cost curve entirely.

The 75% conversion rate in juice is also a benchmark worth remembering. If a supplier claims a novel process, ask for their yield and conversion data. Ask about side products. Ask whether the allulose stays in the final juice or requires removal and purification. The gap between lab results and plant-scale reality can be large.

FAQ

Can the multi-enzyme cascade from the review be used in any beverage? The paper describes juice biotransformation, not every beverage matrix. Enzyme activity, pH, and juice solids all affect performance. Ask your ingredient supplier for validation in your application.

Does China’s approval change how I should source allulose? China’s NHC approval allows allulose as a novel food ingredient there. If you sell into China, confirm current use levels and labeling rules with a regulatory specialist.

What is the main technology to watch? The review points to enzyme engineering and multi-enzyme systems. Those are the areas most likely to shift production costs and supply security in the next few years.

Allulose production is not static. The technologies in this review could help lower costs, improve purity, and open new application formats. The smart move is to track them before they become selling points in your next negotiation.